AR and breast cancer: Since miR-9-5p over-expression decreases BC cell proliferation, our findings rise the very provocative question whether AR antagonists might actually weaken the anti-proliferative effects of miR-9-5p, by preventing androgen-induced up-regulation of miR-9-5p in BC cells.